Evidence map›Paper›PMID 35207581›Full record

ReviewLife (Basel, Switzerland)2022

Resveratrol and Reproductive Health.

Radmila Novakovic, Jovana Rajkovic, Milos Gostimirovic, Ljiljana Gojkovic-Bukarica, Nebojsa Radunovic

Open access · goldAbstract readReview
In one paragraph

Review in Life (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Endometriosis and Nutrition: Therapeutic Perspectives.Journal of clinical medicine · 2025
    Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Physiology and Pathophysiology of the Placenta.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Radmila NovakovicInstitute of Pharmacology, Medical Faculty, Clinical Pharmacology and Toxicology, University of Belgrade, 11129 Belgrade, Serbia.ORCID 0000-0002-1097-2060
Jovana RajkovicInstitute of Pharmacology, Medical Faculty, Clinical Pharmacology and Toxicology, University of Belgrade, 11129 Belgrade, Serbia.ORCID 0000-0002-6173-2219
Milos GostimirovicInstitute of Pharmacology, Medical Faculty, Clinical Pharmacology and Toxicology, University of Belgrade, 11129 Belgrade, Serbia.
Ljiljana Gojkovic-BukaricaInstitute of Pharmacology, Medical Faculty, Clinical Pharmacology and Toxicology, University of Belgrade, 11129 Belgrade, Serbia.
Nebojsa RadunovicDepartment of Medical Sciences, Serbian Academy of Sciences and Arts, 11129 Belgrade, Serbia.
University of Belgrade · RSSerbian Academy of Sciences and Arts · RS

Funding

Innovation fund Republics of Serbia 50138Ministry of Education, Science and Technology of the Republic of Serbia OI175064/200110 and TR31020/200110
6 · The paper itself

Abstract

Resveratrol (RSV), a plant-derived polyphenol, demonstrates broad-spectrum health benefits, including anti-proliferative, anti-inflammatory, antidiabetic, anti-ischemic and antioxidant effects. The aim of this review is to give an important heads-up regarding the influence of RSV as a phytoestrogen, RSV effects on most common pregnancy-related complications, as well as its impact on the embryogenesis, spermatogenesis, and women's reproductive health. Considering the important implications of RSV on human reproductive health, this overview could provide a groundwork, encouraging more detailed research at the clinical level.

Indexed as

dysmenorrheaembryogenesisendometriosisphytoestrogenpolycystic ovary syndromepolyphenolspregnancyresveratrolumbilical blood vesseluterine contractility

Identifiers

PMID35207581
PMCPMC8875092
OpenAlexW4213033691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.